Understanding the barriers to RMMRs

Residential medication management reviews have proven to be beneficial in identifying medicine-related problems, so why are they so under-utilised?

Life-changing tales from pharmacists across Australia

With World Patient Safety Day just passed and World Pharmacists Day around the corner, AP asked pharmacists to share their proudest moments. 

Breathing new life into COPD diagnosis and treatment

Prevention, early diagnosis and optimal treatment are essential to reduce the progression of this irreversible disease.

Giving a voice back to elderly patients

Yesterday’s National Medicine Symposium delivered a stark critique of how our health system is failing older patients – and how to fix it.

Breaking the seal

These are the four areas pharmacists need to consider when manipulating or repackaging commercial products.

Vyvanse® (lisdexamfetamine dimesilate) for treatment of adults with ADHD

Vyvanse® (lisdexamfetamine dimesilate) for treatment of adults with ADHD: PBS listed from 1 February 20211,2